Dyadic International has spent some two decades developing its C1 Technology Platform, a fungal expression system intended to accelerate development, lower production costs, and improve the performance of biologic vaccines and drugs at commercial scales large or small . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post Off Message: Dyadic Fights COVID-19 with a Fungus appeared first on GEN – Genetic Engineering and Biotechnology News.

Source